[
  {
    "ts": null,
    "headline": "Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports",
    "summary": "The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times.  The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset.  Thermo Fisher did not immediately respond to a Reuters' request for comment.",
    "url": "https://finnhub.io/api/news?id=d81cd157930c5d181440c74345e8485393a24c0a495d00a63a2ade8e92ba2f8f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749772439,
      "headline": "Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports",
      "id": 135224571,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times.  The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset.  Thermo Fisher did not immediately respond to a Reuters' request for comment.",
      "url": "https://finnhub.io/api/news?id=d81cd157930c5d181440c74345e8485393a24c0a495d00a63a2ade8e92ba2f8f"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher aims to sell parts of its diagnostics business for $4 billion, FT reports",
    "summary": "Thermo Fisher Scientific hasput part of its diagnostics unit up for sale for about $4billion in an attempt to offload some of its low-growth assets,the Financial Times reported on Thursday, citing...",
    "url": "https://finnhub.io/api/news?id=c8543d7c949e7aac284b6ea7c35a7349997db23eb54106ef1f1efeccc511f347",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749754940,
      "headline": "Thermo Fisher aims to sell parts of its diagnostics business for $4 billion, FT reports",
      "id": 135224220,
      "image": "",
      "related": "TMO",
      "source": "Finnhub",
      "summary": "Thermo Fisher Scientific hasput part of its diagnostics unit up for sale for about $4billion in an attempt to offload some of its low-growth assets,the Financial Times reported on Thursday, citing...",
      "url": "https://finnhub.io/api/news?id=c8543d7c949e7aac284b6ea7c35a7349997db23eb54106ef1f1efeccc511f347"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Genetics Center Selects Olink Explore Ht for Landmark Proteomics Study of 200,000 Patient Samples",
    "summary": "Thermo Fisher Scientific announced that the Regeneron Genetics Center®? has selected the Olink Explore HT proteomics platform for a large-scale proteomics investigation involving nearly 200,000...",
    "url": "https://finnhub.io/api/news?id=c11918fd447cadf3876ff89a450c6656bde9928196de4c7f7587c0c4a949dffb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749747952,
      "headline": "Regeneron Genetics Center Selects Olink Explore Ht for Landmark Proteomics Study of 200,000 Patient Samples",
      "id": 135223595,
      "image": "",
      "related": "TMO",
      "source": "Finnhub",
      "summary": "Thermo Fisher Scientific announced that the Regeneron Genetics Center®? has selected the Olink Explore HT proteomics platform for a large-scale proteomics investigation involving nearly 200,000...",
      "url": "https://finnhub.io/api/news?id=c11918fd447cadf3876ff89a450c6656bde9928196de4c7f7587c0c4a949dffb"
    }
  },
  {
    "ts": null,
    "headline": "Impax Global Opportunities Fund Q1 2025 Commentary",
    "summary": "The fund underperformed the benchmark during the last quarter.",
    "url": "https://finnhub.io/api/news?id=55ef6bc7cae26e7ed6f37f450a70499c47409f0159c8a81d6fd7d66fb953d33b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749738720,
      "headline": "Impax Global Opportunities Fund Q1 2025 Commentary",
      "id": 135222131,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2149339098/image_2149339098.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "The fund underperformed the benchmark during the last quarter.",
      "url": "https://finnhub.io/api/news?id=55ef6bc7cae26e7ed6f37f450a70499c47409f0159c8a81d6fd7d66fb953d33b"
    }
  }
]